<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33219470</PMID><DateCompleted><Year>2021</Year><Month>11</Month><Day>22</Day></DateCompleted><DateRevised><Year>2021</Year><Month>11</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-1912</ISSN><JournalIssue CitedMedium="Internet"><Volume>394</Volume><Issue>5</Issue><PubDate><Year>2021</Year><Month>May</Month></PubDate></JournalIssue><Title>Naunyn-Schmiedeberg's archives of pharmacology</Title><ISOAbbreviation>Naunyn Schmiedebergs Arch Pharmacol</ISOAbbreviation></Journal><ArticleTitle>Astragaloside IV and echinacoside benefit neuronal properties via direct effects and through upregulation of SOD1 astrocyte function in vitro.</ArticleTitle><Pagination><StartPage>1019</StartPage><EndPage>1029</EndPage><MedlinePgn>1019-1029</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00210-020-02022-w</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS), also known as a major type of motor neuron disease, is a disease characterized by the degeneration of both upper and lower motor neurons. Astragaloside IV (AST) is one of the most effective compounds isolated from Astragalus membranaceus. Echinacoside (ECH) is also an active constituent in Cistanche tubulosa. These two herbs had been used in treating disease described like ALS in ancient China under the guidance of traditional Chinese medicine theory and now they are still being used extensively for ALS in current Chinese medicine practice, but whether AST or ECH has effect on ALS disease condition is still unclear. Survivals of primary cultured neuron and astrocyte were determined by the MTS assay. Proteins including GLT1 and GFAP, from SOD1 G93A Tg (transgenic) astrocyte lysate were determined by Western blot. Synaptic markers, PSD95 and VGLUT1, were stained by immunofluorescence and observed by a confocal microscope. Proper dilution of AST and ECH was confirmed to be not harmful to both astrocytes and neurons. AST and ECH enhanced neuronal synaptic markers density or intensity/area in different aspects. Both AST and ECH could significantly rescue SOD1 astrocyte conditional medium-treated neuronal survival and synapse loss. Ten micromolars ECH could significantly rescue the suppressed GLT1 level expressed by SOD1 Tg astrocyte. This present research proved that AST and ECH could benefit neuronal properties and rescue certain dysfunction, such as GLT1 low expression, loss of neuron-supporting function, of astrocytes under SOD1 condition.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tian</LastName><ForeName>Yang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Beijing University of Chinese Medicine, Beijing, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Tufts University School of Medicine, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jin</LastName><ForeName>Shijie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Tufts University School of Medicine, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Promes</LastName><ForeName>Vanessa</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Tufts University School of Medicine, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Xuemei</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Central Laboratory, Dongfang Hospital, Beijing University of Chinese Medicine, Beijing, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yunling</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Xiyuan Hospital, China Academy of Chinese Medical Science, Beijing, People's Republic of China. yunlingzhang2004@126.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>11</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Naunyn Schmiedebergs Arch Pharmacol</MedlineTA><NlmUniqueID>0326264</NlmUniqueID><ISSNLinking>0028-1298</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D027342">Excitatory Amino Acid Transporter 2</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006027">Glycosides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012503">Saponins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C493396">Slc1a2 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014315">Triterpenes</NameOfSubstance></Chemical><Chemical><RegistryNumber>3A592W8XKE</RegistryNumber><NameOfSubstance UI="C052064">astragaloside A</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="C000606291">Sod1 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical><Chemical><RegistryNumber>I04O1DT48T</RegistryNumber><NameOfSubstance UI="C060297">echinacoside</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D027885" MajorTopicYN="N">Astragalus propinquus</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001253" MajorTopicYN="N">Astrocytes</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D031671" MajorTopicYN="N">Cistanche</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D027342" MajorTopicYN="N">Excitatory Amino Acid Transporter 2</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006027" MajorTopicYN="N">Glycosides</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012503" MajorTopicYN="N">Saponins</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014315" MajorTopicYN="N">Triterpenes</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015854" MajorTopicYN="N">Up-Regulation</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">Astragaloside IV</Keyword><Keyword MajorTopicYN="N">Echinacoside</Keyword><Keyword MajorTopicYN="N">GLT1</Keyword><Keyword MajorTopicYN="N">Neuronal properties</Keyword><Keyword MajorTopicYN="N">SOD1</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>6</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>11</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>11</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>11</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>11</Month><Day>21</Day><Hour>5</Hour><Minute>37</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33219470</ArticleId><ArticleId IdType="doi">10.1007/s00210-020-02022-w</ArticleId><ArticleId IdType="pii">10.1007/s00210-020-02022-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Allen NJ, Eroglu C (2017) Cell biology of astrocyte-synapse interactions. Neuron. 96(3):697&#x2013;708</Citation><ArticleIdList><ArticleId IdType="pubmed">29096081</ArticleId><ArticleId IdType="pmc">5687890</ArticleId></ArticleIdList></Reference><Reference><Citation>An T, Shi P, Duan W, Zhang S, Guo Y (2014) Oxidative stress and autophagic alteration in brainstem of SOD1-G93A mouse model of ALS. Mol Neurobiol 49(3):1435&#x2013;1448</Citation><ArticleIdList><ArticleId IdType="pubmed">24390572</ArticleId></ArticleIdList></Reference><Reference><Citation>Bendotti C, Tortarolo M, Suchak SK, Calvaresi N, Carvelli L, Bastone A, Rizzi M, Rattray M, Mennini T (2008) Transgenic SOD1 G93A mice develop reduced GLT-1 in spinal cord without alterations in cerebrospinal fluid glutamate levels. J Neurochem 79(4):737&#x2013;746</Citation></Reference><Reference><Citation>Bo&#xa0;P (2011) Traditional Chinese internal medicine, 2nd edn. People&#x2019;s Medical Publishing House,&#xa0;Beijing</Citation></Reference><Reference><Citation>Bruijn LI, Becher MW, Lee MK, Anderson KL, Cleveland DW (1997) ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron. 18(2):327&#x2013;338</Citation><ArticleIdList><ArticleId IdType="pubmed">9052802</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan WS, Durairajan SSK, Lu JH, Wang Y, Li M (2009) Neuroprotective effects of astragaloside IV in 6-hydroxydopamine-treated primary nigral cell culture. Neurochem Int 55(6):414&#x2013;422</Citation><ArticleIdList><ArticleId IdType="pubmed">19409437</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang CP, Liu YF, Lin HJ, Hsu CC, Lin KC (2015) Beneficial effect of astragaloside on Alzheimer&#x2019;s disease condition using cultured primary cortical cells under &#x3b2;-amyloid exposure. Mol Neurobiol 53(10):7329&#x2013;7340</Citation><ArticleIdList><ArticleId IdType="pubmed">26696494</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen R, Shao H, Lin S, Zhang J-J, Xu K-Q (2011) Treatment with Astragalus membranaceus produces antioxidative effects and attenuates intestinal mucosa injury induced by intestinal ischemia-reperfusion in rats. Am J Chin Med 39(05):879&#x2013;887</Citation><ArticleIdList><ArticleId IdType="pubmed">21905279</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiu (1995) Age-dependent penetrance of disease in a transgenic mouse model of familial amyotrophic lateral sclerosis. Mol Cell Neurosci 6(4):349&#x2013;362</Citation><ArticleIdList><ArticleId IdType="pubmed">8846004</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng M, Zhao JY, Tu PF, Jiang Y, Li ZB, Wang YH (2004) Echinacoside rescues the SHSY5Y neuronal cells from TNFalpha-induced apoptosis. Eur J Pharmacol 505(1&#x2013;3):11&#x2013;18</Citation><ArticleIdList><ArticleId IdType="pubmed">15556132</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Giorgio FP, Carrasco MA, Siao MC, Maniatis T, Eggan K (2007) Non-cell autonomous effect of glia on motor neurons in an embryonic stem cell-based ALS model. Nat Neurosci 10(5):608&#x2013;614</Citation><ArticleIdList><ArticleId IdType="pubmed">17435754</ArticleId><ArticleId IdType="pmc">3139463</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo H (2003) Increased expression of the glial glutamate transporter EAAT2 modulates excitotoxicity and delays the onset but not the outcome of ALS in mice. Hum Mol Genet 12(19):2519&#x2013;2532</Citation><ArticleIdList><ArticleId IdType="pubmed">12915461</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurney M, Pu H, Chiu A, Dal Canto M, Polchow C, Alexander D, Caliendo J, Hentati A, Kwon Y, Deng H et al (1994) Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science 264(5166):1772&#x2013;1775</Citation><ArticleIdList><ArticleId IdType="pubmed">8209258</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardiman O, Al-Chalabi A, Chio A, Corr EM, Logroscino G, Robberecht W et al (2017) Amyotrophic lateral sclerosis. Nat Rev Dis Prim 3(1):1&#x2013;19</Citation></Reference><Reference><Citation>Hayashi Y, Homma K, Ichijo H (2016) SOD1 in neurotoxicity and its controversial roles in SOD1 mutation-negative ALS. Adv Biol Regul 60:95&#x2013;104</Citation><ArticleIdList><ArticleId IdType="pubmed">26563614</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu H, Yang R, Jin G, Zhang X, Xia H, Xu Y (2016) Effect of astragaloside IV on neural stem cell transplantation in Alzheimer&#x2019;s disease rat models. Evid Based Complement Alternat Med 2016:1&#x2013;8</Citation></Reference><Reference><Citation>Kiernan MC, Vucic S, Cheah BC, Turner MR, Eisen A, Hardiman O, Burrell JR, Zoing MC (2011) Amyotrophic lateral sclerosis. Lancet 377(9769):942&#x2013;955</Citation><ArticleIdList><ArticleId IdType="pubmed">21296405</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuang R, Sun Y, Yuan W, Lei L, Zheng X (2009) Protective effects of echinacoside, one of the phenylethanoid glycosides, on H<sub>2</sub>O<sub>2</sub>-induced&#xa0;cytotoxicity in PC12 cells. Planta Med 75(14):1499&#x2013;1504</Citation></Reference><Reference><Citation>Lewis K, Rasmussen A, Bennett W et al (2014) Microglia and motor neurons during disease progression in the SOD1 G93A mouse&#xa0;model of amyotrophic lateral sclerosis: changes in arginase1 and inducible nitric oxide synthase. J Neuroinflammation 11:55</Citation></Reference><Reference><Citation>Li Z, Huinuan L, Long G, Jingwen G, Chi-Meng T (2016) Herba Cistanche (Rou Cong-Rong): one of the best pharmaceutical gifts of traditional Chinese medicine. Front Pharmacol 7:41</Citation><ArticleIdList><ArticleId IdType="pubmed">26973528</ArticleId><ArticleId IdType="pmc">4771771</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, Wang X, Han C, Wang X, Xing G, Zhou L, Li G, Niu Y (2013) Astragaloside IV suppresses collagen production of activated hepatic stellate cells via oxidative stress-mediated p38 MAPK pathway. Free Radic Biol Med 60:168&#x2013;176</Citation><ArticleIdList><ArticleId IdType="pubmed">23459070</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, Lillo C, Jonsson PA, Velde CV, Cleveland DW (2004) Toxicity of familial ALS-linked SOD1 mutants from selective recruitment to spinal mitochondria. Neuron. 43(1):5&#x2013;17</Citation><ArticleIdList><ArticleId IdType="pubmed">15233913</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, Lingling Y, Yanhong D, Bo Z, Xueqin M (2018) Echinacoside, an inestimable natural product in treatment of neurological and other disorders. Molecules 23(5):1213</Citation><ArticleIdList><ArticleId IdType="pmc">6100060</ArticleId></ArticleIdList></Reference><Reference><Citation>Marchetto MC, Muotri AR, Mu Y, Smith AM, Cezar GG, Gage FH (2008) Non-cell-autonomous effect of human SOD1 G37R astrocytes on motor neurons derived from human embryonic stem cells. Cell Stem Cell 3(6):649&#x2013;657</Citation><ArticleIdList><ArticleId IdType="pubmed">19041781</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagai M, Re DB, Nagata T, Chalazonitis A, Jessell TM, Wichterle H, Przedborski S (2007) Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons. Nat Neurosci 10(5):615&#x2013;622</Citation><ArticleIdList><ArticleId IdType="pubmed">17435755</ArticleId><ArticleId IdType="pmc">3799799</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan W, Su X, Bao J, Wang J, Zhou H (2013) Open randomized clinical trial on JWSJZ decoction for the treatment of ALS patients. Evid Based Complement Alternat Med 2013(3):347525</Citation><ArticleIdList><ArticleId IdType="pubmed">24093046</ArticleId><ArticleId IdType="pmc">3777196</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrov D, Mansfield C, Moussy A, Hermine O (2017) ALS clinical trials review: 20 years of failure. Are we any closer to registering a new treatment? Front Aging Neurosci 9:68</Citation></Reference><Reference><Citation>Qin Q, Niu J, Wang Z, Xu W, Qiao Z, Gu Y (2012) Astragalus membranaceus inhibits inflammation via phospho-P38 mitogen-activated protein kinase (MAPK) and nuclear factor (NF)-&#xce;&#xb0;B pathways in advanced glycation end product-stimulated macrophages. Int J Mol Sci 13(7):8379&#x2013;8387</Citation><ArticleIdList><ArticleId IdType="pubmed">22942709</ArticleId><ArticleId IdType="pmc">3430240</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, Donaldson D, Goto J, O&#x2019;Regan JP, Deng HX et al (1993) Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362(6415):59&#x2013;62</Citation><ArticleIdList><ArticleId IdType="pubmed">8446170</ArticleId></ArticleIdList></Reference><Reference><Citation>Sargsyan SA, Blackburn DJ, Barber SC, Monk PN, Shaw PJ (2009) Mutant SOD1 G93A microglia have an inflammatory phenotype and elevated production of MCP-1. Neuroreport. 20(16):1450&#x2013;1455</Citation><ArticleIdList><ArticleId IdType="pubmed">19752764</ArticleId><ArticleId IdType="pmc">2889291</ArticleId></ArticleIdList></Reference><Reference><Citation>Tortarolo M, Crossthwaite AJ, Conforti L, Spencer JP, Williams RJ, Bendotti C, Rattray M (2003) Expression of SOD1 G93A or wild-type SOD1 in primary cultures of astrocytes down-regulates the glutamate transporter GLT-1: lack of involvement of oxidative stress&amp;nbsp. J Neurochem 88(2):481&#x2013;493</Citation></Reference><Reference><Citation>Trotti D, Rolfs A, Danbolt NC, Brown RH, Hediger MA (1999) SOD1 mutants linked to amyotrophic lateral sclerosis selectively inactivate a&#xa0;glial glutamate transporter. Nat Neurosci 2(5):427&#x2013;33</Citation></Reference><Reference><Citation>Turner BJ, Talbot K (2008) Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS. Prog Neurobiol 85(1):94&#x2013;134</Citation><ArticleIdList><ArticleId IdType="pubmed">18282652</ArticleId></ArticleIdList></Reference><Reference><Citation>Valdmanis PN, Belzil VV, Lee J, Dion PA, Rouleau GA (2009) A mutation that creates a pseudoexon in SOD1 causes familial ALS. Ann Hum Genet 73(Pt 6):652&#x2013;657</Citation><ArticleIdList><ArticleId IdType="pubmed">19847927</ArticleId></ArticleIdList></Reference><Reference><Citation>Waites CL, Craig AM, Garner CC (2005) Mechanisms of vertebrate synaptogenesis. Annu Rev Neurosci 28(1):251&#x2013;274</Citation><ArticleIdList><ArticleId IdType="pubmed">16022596</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang N, Shaozhen J, Hao Z, Shanshan M, Lumin Q, Xianglan J (2017) Herba Cistanches: anti-aging. Aging Dis 8(6):740</Citation><ArticleIdList><ArticleId IdType="pubmed">29344414</ArticleId><ArticleId IdType="pmc">5758349</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, Wang Y, Hu J-P, Yu S, Li B-K, Cui Y et al (2016) Astragaloside IV, a natural PPAR&#x3b3; agonist, reduces A&#x3b2; production in Alzheimer&#x2019;s disease through inhibition of BACE1. Mol Neurobiol 54(4):2939&#x2013;2949</Citation><ArticleIdList><ArticleId IdType="pubmed">27023226</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao Q, Zhao W, Beers DR, Yen AA, Xie W, Henkel JS, Appel SH (2007) Mutant SOD1 G93A microglia are more neurotoxic relative to wild-type microglia. J Neurochem 102(6):2008&#x2013;2019</Citation><ArticleIdList><ArticleId IdType="pubmed">17555556</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue B, Huang J, Ma B et al (2019) Astragaloside IV protects primary cerebral cortical neurons from oxygen and glucose deprivation/reoxygenation by activating the PKA/CREB pathway</Citation></Reference><Reference><Citation>You Y, Yan L, Huang L, Huang S, Zhao Z (2010) Anti-apoptosis effect of astragaloside IV on Alzheimer&#x2019;s disease rat model via enhancing the expression of Bcl-2 and Bcl-X1. Scand J Lab Anim Sci 37(2):75&#x2013;82</Citation></Reference><Reference><Citation>Yu W, Lv Z, Zhang L, Gao Z, Chen X, Yang X, Zhong M (2018) Astragaloside IV reduces the hypoxia-induced injury in PC-12 cells by inhibiting expression of miR-124. Biomed Pharmacother 106:419&#x2013;425</Citation><ArticleIdList><ArticleId IdType="pubmed">29990829</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L, Liu Q, Lu L, Zhao X, Gao X, Wang Y (2011) Astragaloside IV stimulates angiogenesis and increases hypoxia-inducible factor-1? Accumulation via phosphatidylinositol 3-kinase/Akt pathway. J Pharmacol Exp Ther 338(2):485&#x2013;491</Citation><ArticleIdList><ArticleId IdType="pubmed">21576377</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang ZG, Wu L, Wang J-l, Yang J-d, Zhang J, Zhang J et al (2012) Astragaloside IV prevents MPP+-induced SH-SY5Y cell death via the inhibition of Bax-mediated pathways and ROS production. Mol Cell Biochem 364(1&#x2013;2):209&#x2013;216</Citation><ArticleIdList><ArticleId IdType="pubmed">22278385</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J, Zhang Z, Xiang J, Cai M, Yu Z, Li X, Wu T, Cai D (2017) Neuroprotective effects of echinacoside on regulating the stress-active p38MAPK and NF-&#x3ba;B p52 signals in the mice model of Parkinson&#x2019;s disease. Neurochem Res 42(4):975&#x2013;985</Citation><ArticleIdList><ArticleId IdType="pubmed">27981472</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao W, Beers DR, Henkel JS, Zhang W, Urushitani M, Julien JP, Appel SH (2010a) Extracellular mutant SOD1 induces microglial-mediated motoneuron injury. Glia. 58(2):231&#x2013;243</Citation><ArticleIdList><ArticleId IdType="pubmed">19672969</ArticleId><ArticleId IdType="pmc">2784168</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Q, Gao J, Li W, Cai D (2010b) Neurotrophic and neurorescue effects of echinacoside in the subacute MPTP mouse model of Parkinson&#x2019;s disease. Brain Res 1346:224&#x2013;236</Citation><ArticleIdList><ArticleId IdType="pubmed">20478277</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Q, Yang X, Cai D, Ye L, Hou Y, Zhang L, Cheng J, Shen Y, Wang K, Bai Y (2016) Echinacoside protects against MPP+-induced neuronal apoptosis via ROS/ATF3/CHOP pathway regulation. Neurosci Bull 32(4):349&#x2013;362</Citation><ArticleIdList><ArticleId IdType="pubmed">27432061</ArticleId><ArticleId IdType="pmc">5563786</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou M , Ling S, Chen H, Pan R (2017) Inhibition of notch signaling pathways contribute to neuroprotection effect by the combination of&#xa0;astragalus membranaceus and ligustrazine in rat model after thrombolysis of cerebral ischaemia. In: IEEE International Conference on Bioinformatics &amp;&#xa0;Biomedicine. IEEE Computer Society,&#xa0;Kansas City</Citation></Reference><Reference><Citation>Zhu M, Lu C, Li W (2013) Transient exposure to echinacoside is sufficient to activate Trk signaling and protect neuronal cells from rotenone. J Neurochem 124(4):571&#x2013;580</Citation><ArticleIdList><ArticleId IdType="pubmed">23189969</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu S, Qi L, Rui YF, Li RX, He XP, Xie ZP (2008) Astragaloside IV inhibits spontaneous synaptic transmission and synchronized Ca2+ oscillations on hippocampal neurons1. Acta Pharmacol Sin 29:57&#x2013;64</Citation><ArticleIdList><ArticleId IdType="pubmed">18158866</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>